Simultaneous Transfemoral Transcatheter Aortic Valve Replacement of a Native Aortic Valve and Transapical Transcatheter Mitral Valve-in-Valve Replacement

Tanya Doctorian, Daniel Serna, Blanding Jones, Arti Choure, Ramdas Pai, Eric Chou, William Mosley
2017 Interventional Cardiology Journal  
With Transcatheter Aortic Valve Replacement (TAVR) revolutionizing the treatment of high-surgical risk patients with severe aortic stenosis, Transcatheter Mitral Valve Replacement (TMVR) is slowly emerging as an off-label therapy for severe mitral valve disease. The case of a 70-year-old female with recurrent history of congestive heart failure has been described. This case demonstrates the simultaneous TAVR and off-label VIV TMVR is a reasonable alternative for highrisk surgical patients with stenotic native and failing bioprosthetic valves.
doi:10.21767/2471-8157.100060 fatcat:7gbzvuns7nhxvjyayi7w5qg7mi